Regulation of cell proliferation by multi-layered phospholipid polymer hydrogel coatings through controlled release of paclitaxel

Biomaterials

Volumn 33, Issue 3, 2012, Pages 954-961

  Choi, Jiyeon ^a   Konno, Tomohiro ^a,b   Takai, Madoka ^a   Ishihara, Kazuhiko ^a,b  

^a UNIVERSITY OF TOKYO   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

2 Methacryloyloxyethyl phosphorylcholine polymer; Cell life cycle analysis; Cell proliferation; Layer by layer process; Multilayered hydrogel

Indexed keywords

2-METHACRYLOYLOXYETHYL PHOSPHORYLCHOLINE; ALTERNATING LAYERS; ANTICANCER DRUG; AQUEOUS MEDIUM; BIOACTIVE AGENTS; BIOACTIVE MOLECULES; BIOMEDICAL DEVICES; BORONIC ACID; BOTTOM LAYERS; CELL CULTURE MEDIUMS; CELL CYCLE; CELL NUMBER; CELL-CYCLE ARREST; CONTROLLED RELEASE; D-GLUCOSE; EXCHANGE REACTION; GROWTH INHIBITION; HIGH CONCENTRATION; HYDROPHOBIC DOMAINS; HYDROPHOBIC MOLECULES; HYDROXYL GROUPS; LAYER-BY-LAYERS; LOW-MOLECULAR WEIGHT; MULTI-LAYERED; PACLITAXEL; PHENYLBORONIC ACIDS; PHOSPHOLIPID POLYMERS; POLYMERIC AGGREGATES; RELEASE PROFILES; WATER-SOLUBLE PHOSPHOLIPID POLYMERS;

ANIMAL CELL CULTURE; CELL PROLIFERATION; CELLS; CYTOLOGY; DIFFUSION BARRIERS; EXPERIMENTS; GLUCOSE; HYDROPHOBICITY; ORGANIC ACIDS; PHOSPHOLIPIDS; POLYMERS; RESERVOIRS (WATER); TITANIUM; TITANIUM ALLOYS;

HYDROGELS;

BENZENEBORONIC ACID; GLUCOSE; PACLITAXEL; POLYVINYL ALCOHOL;

AQUEOUS SOLUTION; ARTICLE; CARCINOMA CELL; CELL COUNT; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; COVALENT BOND; DISSOCIATION; DRUG DIFFUSION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HYDROGEL; MATERIAL COATING; PRIORITY JOURNAL;

CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; HUMANS; HYDROGEL; PACLITAXEL; PHOSPHOLIPIDS; POLYMERS;

EID: 81155137743     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2011.10.006     Document Type: Article

References (44)

1. Bozukova D., Pagnoulle C., Jérôme R., Jérôme C. Polymers in modern ophthalmic implants-Historical background and recent advances. Mater Sci Eng R 2010, 69:63-83.
2. Schliephake H., Scharnweber D. Chemical and biological functionalization of titanium for dental implants. J Mater Chem 2008, 18:2404-2414.
3. Duan K., Wang R. Surface modifications of bone implants through wet chemistry. J Mater Chem 2006, 16:2309-2321.
4. Hallab N., Jacobs J.J., Black J. Hypersensitivity to metallic biomaterials: a review of leukocyte migration inhibition assays. Biomaterials 2000, 21:1301-1314.
5. Anderson J.M. Biological responses to materials. Annu Rev Mater Res 2001, 31:81-110.
6. Lichter J.A., Vliet K.J., Rubner M.F. Design of antibacterial surfaces and interfaces: polyelectrolyte multilayers as a multifunctional platform. Macromolecules 2009, 42:8573-8586.
7. Anderson J.M., Rodrigueza A., Chang D.T. Foreign body reaction to biomaterials. Semin Immunol 2008, 20:86-100.
8. O'Brien B., Carroll W. The evolution of cardiovascular stent materials and surfaces in response to clinical drivers: a review. Acta Biomater 2009, 5:945-958.
9. Schuchert A. The effects of local steroid-elution on high-performance pacing leads. Herzschr Elektrophys 2001, 12:141-147.
10. Moussy F. Implantable glucose sensor: progress and problems. Proc IEEE Sensors 2002, 1:270-273.
11. Moskowitz J.S., Blaisse M.R., Samuel R.E., Hsu H.P., Harris M.B., Martin S.D., et al. The effectiveness of the controlled release of gentamicin from polyelectrolyte multilayers in the treatment of Staphylococcus aureus infection in a rabbit bone model. Biomaterials 2010, 31:6019-6030.
12. Jewell C.M., Lynn D.M. Multilayered polyelectrolyte assemblies as platforms for the delivery of DNA and other nucleic acid-based therapeutics. Adv Drug Deliv Rev 2008, 60:979-999.
13. Macdonald M., Rodriguez N.M., Smith R., Hammond P.T. Release of a model protein from biodegradable self assembled films for surface delivery applications. J Control Release 2008, 131:228-234.
14. Stockton W.B., Rubner M.F. Molecular-level processing of conjugated polymers. 4. Layer-by-layer manipulation of polyaniline via hydrogen-bonding interactions. Macromolecules 1997, 30:2717-2725.
15. Zhong H., Wang J., Jia X., Li Y., Qin Y., Chen J., et al. Fabrication of covalently attached ultrathin films based on dendrimers via h-bonding attraction and subsequent UV irradiation. Macromol Rapid Commun 2001, 22:583-586.
16. Decher G., Hong J.D., Shimit J. Buildup of ultrathin multilayer films by a self-assembly process: III. Consecutively alternating adsorption of anionic and cationic polyelectrolytes on charged surfaces. Thin Solid Films 1992, 210:831-835.
17. Zhang J., Senger B., Vautier D., Picart C., Schaaf P., Voegel J., et al. Natural polyelectrolyte films based on layer-by-layer deposition of collagen and hyaluronic acid. Biomaterials 2005, 26:3353-3361.
18. Tang Z., Wang Y., Podsiadlo P., Kotov N.A. Biomedical applications of layer-by-layer assembly: from biomimetics to tissue engineering. Adv Mater 2006, 18:3203-3224.
19. Kim B.S., Smith R.C., Poon Z., Hammond P.T. MAD (multiagent delivery) nanolayer: delivering multiple therapeutics from hierarchically assembled surface coatings. Langmuir 2009, 25:14086-14092.
20. Wood K.C., Chuang H.F., Batten R.D., Lynn D.M., Hammond P.T. Controlling interlayer diffusion to achieve sustained, multiagent delivery from layer-by-layer thin films. Proc Natl Acad Sci USA 2006, 103:10207-10212.
21. Rowinsky E.K., Donehower R.C. Paclitaxel (Taxol). N Engl J Med 1995, 332:1004-1014.
22. Belotti D., Vergani V., Drudis T., Borsotti P., Pitelli M.R., Viale G., et al. The microtubule-affecting drug paclitaxel has antiangiogenic activity. Clin Cancer Res 1996, 2:1843-1849.
23. Tanabe K., Regar E., Lee C.H., Hoye A., van der Giessen W.J., Serruys P.W. Local drug delivery using coated stents: new developments and future perspectives. Curr Pharm Des 2004, 10:357-367.
24. Ishihara K., Nomura H., Mihara T., Kurita K., Iwasaki Y., Nakabayashi N. Why do phospholipid polymers reduce protein adsorption?. J Biomed Mater Res 1998, 39:323-330.
25. Ishihara K., Aragaki R., Ueda T., Watanabe A., Nakabayashi N. Reduced thrombogenicity of polymers having phospholipid polar groups. J Biomed Mater Res 1990, 24:1069-1077.
26. Sawada S., Iwasaki Y., Nakabayashi N., Ishihara K. Stress response of adherent cells on a polymer blend surface composed of a segmented polyurethane and MPC copolymers. J Biomed Mater Res 2006, 79:476-484.
27. Moro T., Takatori Y., Ishihara K., Konno T., Takigawa Y., Matsushita T., et al. Surface grafting of artificial joints with a biocompatible polymer for preventing periprosthetic osteolysis. Nat Mater 2004, 3:829-836.
28. Snyder T.A., Tsukui H., Kihara S., Akimoto T., Litwak K.N., Kameneva M.V., et al. Preclinical biocompatibility assessment of the EVAHEART ventricular assist device: coating comparison and platelet activation. J Biomed Mater Res A 2007, 81:85-92.
29. Collingwood R., Gibson L., Sedlik S., Virmani R., Carter A.J. Stent-based delivery of ABT-578 via a phosphorylcholine surface coating reduces neointimal formation in the porcine coronary model. Catheter Cardiovasc Interv 2005, 65:227-232.
30. Burke S.E., Kuntz R.E., Schwartz L.B. Zotarolimus (ABT-578) eluting stents. Adv Drug Deliv Rev 2006, 58:437-446.
31. Konno T., Ishihara K. Temporal and spatially controllable cell encapsulation using a water-soluble phospholipid polymer with phenylboronic acid moiety. Biomaterials 2007, 28:1770-1777.
32. Choi J., Konno T., Matsuno R., Takai M., Ishihara K. Surface immobilization of biocompatible phospholipid polymer multilayered hydrogel on titanium alloy. Colloid Surf B 2008, 67:216-223.
33. Choi J., Konno T., Takai M., Ishihara K. Controlled drug release from multilayered phospholipid polymer hydrogel on titanium alloy surface. Biomaterials 2009, 30:5201-5208.
34. Ishihara K., Iwasaki Y., Nakabayashi N. Polymeric lipid nanosphere consisting of water-soluble poly(2-methacryloyloxyethyl phosphorylcholine-co-n-butyl methacrylate). Polym J 1999, 31:1231-1236.
35. Konno T., Watanabe J., Ishihara K. Enhanced solubility of paclitaxel using water-soluble and biocompatible 2-methacryloyloxyethyl phosphorylcholine polymers. J Biomed Mater Res 2003, 65A:210-215.
36. Wada M., Jinno H., Ueda M., Ikeda T., Kitajima M., Konno T., et al. Efficacy of an MPC-BMA co-polymer as a nanotransporter for paclitaxel. Anticancer Res 2007, 27:1431-1435.
37. Ishihara K., Ueda T., Nakabayashi N. Preparation of phospholipid polymers and their properties as polymer hydrogel membranes. Polym J 1990, 22:355-360.
38. Lin C., Metters A. Hydrogels in controlled release formulations: network design and mathematical modeling. Adv Drug Deliv Rev 2006, 58:1379-1408.
39. Kikuchi A., Suzuki K., Okabayashi O., Hoshino H., Kataoka K., Sakurai Y., et al. Glucose-sensing electrode coated with polymer complex gel containing phenylboronic acid. Anal Chem 1996, 68:823-828.
40. Shiino D., Murata Y., Kubo A., Kim Y.J., Kataoka K., Koyama Y., et al. Amine containing phenylboronic acid gel for glucose-responsive insulin release under physiological pH. J Control Release 1995, 37:269-276.
41. Zhang Z., Feng S.S. The drug encapsulation efficiency, in vitro drug release, cellular uptake and cytotoxicity of paclitaxel-loaded poly(lactide)-tocopheryl polyethylene glycol succinate nanoparticles. Biomaterials 2006, 27:4025-4033.
42. Jordan M.A., Toso R.J., Thrower D., Wilson L. Mechanism of mitotic block and inhibition of cell proliferation by taxol at low concentrations. Proc Natl Acad Sci 1993, 90:9552-9556.
43. Wang T.H., Wang H.S., Soong Y.K. Paclitaxel-induced cell death: where the cell cycle and apoptosis come together. Cancer 2000, 88:2619-2628.
44. Liao P.C., Lieu C.H. Cell cycle specific induction of apoptosis and necrosis by paclitaxel in the leukemic U937 cells. Life Sci 2005, 76:1623-1639.